JILLIAN ROSS: Open Payments
NPI 1689438681 · ALBUQUERQUE, NM. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$345 in 11 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $143 · 2025 $345
Food & beverage: $345
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $166 |
| ABIOMED | 3 | $76 |
| Novartis Pharmaceuticals Corporation | 1 | $28 |
| Novo Nordisk Inc | 1 | $21 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $20 |
| Alnylam Pharmaceuticals Inc. | 1 | $17 |
| Amgen Inc. | 1 | $16 |
Products named: LOKELMA, LEQVIO, WAINUA, Wegovy, Kerendia, AMVUTTRA, REPATHA, FARXIGA.
Industry payments across NM — which companies pay providers there.
